The newly published article by Hadaegh's group [1] points to paradoxical aspects regarding the pathogenesis of cardiovascular disease (CVD), yet without optimal evaluation and interpretation. Utilizing a large sample of the Tehran Lipid and Glucose study cohort, authors investigated the predictive value of hypertriglyceridemic waist (HtgW) for CVD and mortality. Authors concluded that, after adjustment for potential confounders, though inwomen incident CVD risk was significantly increased all-cause mortality was inversely associated with HtgW in each gender and CVD mortality in men. HtgW is a crucially important distinct phenotype leading to excess cardiometabolic risk. It is a state of enhanced subclinical inflammation and autoimmune activation in either gender [2]. Sexand age-adjusted differences of this phenotype in the Turkish Adult Risk Factor study participants bystratifying into the categories of “healthy”, onlyabdominal obesity, hypertriglyceridemia (N1.7 mmol/L) aloneandHtgWemergedas follows. Compared with the “healthy” category, HtgW had significantly higher bloodpressure (BP), total, low-density lipoprotein andnon-highdensity lipoprotein(HDL)-cholesterol, apolipoprotein B, glucose, Creactive protein and complement C3 (a marker of autoimmunity) concentrations, and lowerHDL-cholesterol levels andprevalence ineach sex of current smoking. Individuals with HtgW further displayed lower circulating Lp(a), adiponectin, and sex hormone-binding globulin (SHBG). Collectively, these aspects strongly support the notion that HtgW phenotype is driven by oxidized phospholipids, particularly concentrated on Lp(a) particles which also become gradually oxidized, resulting in damaged epitopes that render themnot being captured fully by the immunoassay. The consequence is on one hand an “apparently” low Lp(a) level, on the other higher apoB-containing lipoproteins, because apoB itself, not damaged in the pro-inflammatory milieu, is assayed adequately. Protective plasma proteins such as apoA-I, HDL, adiponectin and SHBG combat the slow process of subclinical inflammation and autoimmune activation but, eventually, may each be converted pro-inflammatory during the stage of HtgW (as yet unpublished findings). In people with this phenotype, adjusting for total and HDLcholesterol, BP, and CRP has inherent bias [3] because HtgW represents enhanced pro-inflammatory state with elevated apoB, and resultant elevated BP. As regards adjusting for smoking status, this is a fallacy by causal relationship, because non-smoking in many ethnicities contributes to drive pro-inflammatory state, and current smoking induces avoidance of abdominal obesity [4,5] and may inhibit the autoimmune process [2,6]. A second important factor that deforms the paradoxical assessment is that HtgW phenotype leads not only to cardiovascular disease and death from it but also to other diseases, such as chronic kidney disease [7], diabetes mellitus [8] and presumably also to certain types of cancer, so that overall mortality is influenced by competing causes. Adjustment for conventional cardiovascular risk factors reduces the attributable part for cardiovascular mortality without substantially modifying mortality due to other causes. Inappropriate evaluation of the huge clinical significance of HtgW maymislead to imperfect guidelines anderraticmedical practice.Hence, the clinical significance of HtgWshouldbeput into proper context in the future by further related research across various ethnicities and appropriate assessment.
Read full abstract